Scarcity of data and siloed data sources lead to gaps in information that create challenges in study design. Additionally, the increase in trial complexity, which has seen a 600% increase in collected data points, contributes to negative impact on a variety of trial performance outcomes. Evidence-based insights help study teams iterate upon ideas that can lead to lean study designs, resulting in reduced data points, decreased costs, and less deviations.
This webinar uncovers how technology and analytics can be applied to address key areas during study design/synopsis development.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
.svg){kind=icon}
